Kamila Czene

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Breast Cancer Risk

Randomized Controlled Trial

Metabolic Syndrome

Top Venues

Journal of the National Cancer Institute

Statistics in medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Letizia Orsini, Kamila Czene, Keith Humphreys
Random effects models of tumour growth for investigating interval breast cancer. Statistics in medicine 43 (15) (2024)
Erwei Zeng, Wei He, Arvid Sjölander, Jenny Bergqvist, Fang Fang, Kamila Czene
Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis. Journal of the National Cancer Institute 116 (6) (2024)
Qingyang Xiao, Xinhe Mao, Alexander Ploner, Felix Grassmann, Juan Rodriguez, Mikael Eriksson, Per Hall, Kamila Czene
Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer. Journal of the National Cancer Institute 116 (6) (2024)
Qingyang Xiao, Xinhe Mao, Alexander Ploner, Felix Grassmann, Juan Rodriguez, Mikael Eriksson, Per Hall, Kamila Czene
Cancer risks among first-degree relatives of women with a genetic predisposition to breast cancer. Journal of the National Cancer Institute 116 (6) (2024)
Erwei Zeng, Wei He, Arvid Sjölander, Jenny Bergqvist, Fang Fang, Kamila Czene
Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis. Journal of the National Cancer Institute 116 (6) (2024)
Letizia Orsini, Kamila Czene, Keith Humphreys
Random effects models of tumour growth for investigating interval breast cancer. Statistics in medicine 43 (15) (2024)
Letizia Orsini, Kamila Czene, Keith Humphreys
Random effects models of tumour growth for investigating interval breast cancer. Statistics in medicine (2024)
Mikael Eriksson, Kamila Czene, Celine Vachon, Emily F Conant, Per Hall
A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer. Cancers 15 (12) (2023)
Mikael Eriksson, Kamila Czene, Celine Vachon, Emily F Conant, Per Hall
A Clinical Risk Model for Personalized Screening and Prevention of Breast Cancer. Cancers 15 (12) (2023)
Mikael Eriksson, Stamatia V Destounis, Kamila Czene, Andrew Zeiberg, Robert Day, Sally D Herschorn, Kathy Schilling, Per Hall
A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care. Science translational medicine 14 (644) (2022)
Magnus Bäcklund, Mikael Eriksson, Marike Gabrielsson, Mattias Hammarström, Steve Quay, Jenny Bergqvist, Roxanna Hellgren, Kamila Czene, Per Hall
Topical Endoxifen for Mammographic Density Reduction-A Randomized Controlled Trial. The oncologist 27 (7) (2022)
Magnus Bäcklund, Mikael Eriksson, Mattias Hammarström, Linda Thoren, Jenny Bergqvist, Sara Margolin, Roxanna J Hellgren, Yvonne Wengström, Marike Gabrielsson, Kamila Czene, Per Hall
Time to Mammographic Density Decrease After Exposure to Tamoxifen. The oncologist 27 (7) (2022)
Erwei Zeng, Wei He, Arvid Sjölander, Jenny Bergqvist, Kamila Czene
Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer. Cancer research 82 (19) (2022)
Felix Grassmann, Haomin Yang, Mikael Eriksson, Shadi Azam, Per Hall, Kamila Czene
Mammographic features are associated with cardiometabolic disease risk and mortality. European heart journal 42 (34) (2021)
Johanna Holm, Nancy Yiu-Lin Yu, Annelie Johansson, Alexander Ploner, Per Hall, Linda Sofie Lindström, Kamila Czene
Concordance of Immunohistochemistry-Based and Gene Expression-Based Subtyping in Breast Cancer. JNCI cancer spectrum 5 (1) (2020)